Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-11-020285
Filing Date
2011-04-05
Accepted
2011-04-05 17:02:53
Documents
1
Period of Report
2011-03-23

Document Format Files

Seq Description Document Type Size
1 v217617_ex.html 4  
1 v217617_ex.xml 4 3068
  Complete submission text file 0001144204-11-020285.txt   4537
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2483 NE JULEP STREET ISSAQUAH WA 98029
Business Address
WILSON GLYNN (Reporting) CIK: 0001405625 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27239 | Film No.: 11740809